3HQZ image
Deposition Date 2009-06-08
Release Date 2009-08-04
Last Version Date 2023-09-06
Entry Detail
PDB ID:
3HQZ
Title:
Discovery of novel inhibitors of PDE10A
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.22
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
H 3
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Gene (Uniprot):Pde10a
Chain IDs:A
Chain Length:380
Number of Molecules:1
Biological Source:Rattus norvegicus
Primary Citation
Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia
J.Med.Chem. 52 5188 5196 (2009)
PMID: 19630403 DOI: 10.1021/jm900521k

Abstact

By utilizing structure-based drug design (SBDD) knowledge, a novel class of phosphodiesterase (PDE) 10A inhibitors was identified. The structure-based drug design efforts identified a unique "selectivity pocket" for PDE10A inhibitors, and interactions within this pocket allowed the design of highly selective and potent PDE10A inhibitors. Further optimization of brain penetration and drug-like properties led to the discovery of 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920). This PDE10A inhibitor is the first reported clinical entry for this mechanism in the treatment of schizophrenia.

Legend

Protein

Chemical

Disease

Primary Citation of related structures